Nanotechnology Now - Press Release: Reportlinker Adds Nanotechnology in Medical Applications: The Global Market

Home > Press > Reportlinker Adds Nanotechnology in Medical Applications: The Global Market

Abstract:
Forecast the market and its compound annual growth rate (CAGR) from 2009 to 2014

Reportlinker Adds Nanotechnology in Medical Applications: The Global Market

Posted on January 4th, 2010

Discusses clinical applications to be developed, including cancer diagnosis and therapy, drug-delivery systems, biosensors, bone and dental repair, and coatings, such as those for stents.

Describes nanotechnologies such as fullerenes (buckyballs) as drug carriers, nanotubules for drug delivery, nanoparticles (e.g., liposomes, dendrimers, micelles), nanospheres, and molecular nanotechnology.

Explains that financing for start-up businesses is derived from various sources, including venture capital and government grants, and that there is also a considerable amount of activity in university research laboratories and scientific foundations.

Chapter- 1: INTRODUCTION -- Complimentary

STUDY GOALS AND OBJECTIVES 1

REASONS FOR DOING THE STUDY 1

INTENDED AUDIENCE 1

SCOPE OF REPORT 2

MARKET ANALYSES AND FORECASTS 2

METHODOLOGY 2

INFORMATION SOURCES 2

ANALYST CREDENTIALS 3

RELATED BCC REPORTS 3

BCC ONLINE SERVICES 3

DISCLAIMER 3

Chapter-2: SUMMARY

RESEARCH AND COMMERCIALIZATION 4

APPLICATIONS 4

DRUG DELIVERY 4

DRUGS AND THERAPY 5

IN VIVO IMAGING 5

IN VITRO DIAGNOSTICS 5

BIOMATERIALS 5

ACTIVE IMPLANTS 5

MARKET 5

SUMMARY TABLE NANOMEDICAL GLOBAL SALES BY THERAPEUTIC AREA, THROUGH 2014 ($
BILLIONS) 6

SUMMARY FIGURE NANOMEDICAL GLOBAL SALES BY THERAPEUTIC AREA, 2006-2014 ($
BILLIONS) 6

Chapter-3: OVERVIEW

MEDICAL NANOTECHNOLOGY: NANOMEDICINE 7

FUTURE POSSIBILITIES 7

MARKET POTENTIAL 8

ABOUT NANOTECHNOLOGY 8

ABOUT NANOTECHNOLOGY (CONTINUED) 9

THE MANY USES OF NANOTECHNOLOGY 10

MEDICAL APPLICATIONS 10

ENVIRONMENTAL APPLICATIONS 10

MILITARY APPLICATIONS 11

COSMETICS 11

APPLICATIONS IN DEVELOPMENT 11

THE TOOLS OF NANOTECHNOLOGY 12

C60/FULLERENES 12

CARBON NANOTUBES 12

NANOPARTICLES 12

NANOWIRES 13

MOLECULAR NANOTECHNOLOGY 13

RISKS OF NANOTECHNOLOGY 13

POISON/TOXICITY 13

NANOTECHNOLOGY IN THE MARKETPLACE 14

NANOTECHNOLOGY IN ... (CONTINUED) 15

NANOTECHNOLOGY IN ... (CONTINUED) 16

Chapter-4: NANOMEDICINE

DEVELOPMENT OF NANOMEDICAL TECHNOLOGIES 17

TABLE 1 NANOMEDICINE TIMESCALE 17

TABLE 2 MAIN NANOTECHNOLOGIES USED IN MEDICINE, WITH APPLICATIONS 18

LIPOSOMES 18

TABLE 3 MARKETED LIPOSOME NANOPHARMACEUTICALS 19

DENDRIMERS 20

TABLE 4 DENDRIMER PRODUCTS IN ADVANCED DEVELOPMENT 20

NANOCRYSTALS 20

TABLE 5 NANOCRYSTAL PHARMACEUTICALS 21

MICELLES 21

TABLE 6 MARKETED AND DEVELOPMENTAL PRODUCTS IN MICELLE FORM 22

FULLERENES 22

POLYMERIC NANOPARTICLES 23

THERAPEUTIC USES OF NANOMEDICINE 24

CANCER DIAGNOSTICS AND THERAPY 24

Silica Nanospheres 24

Nanoscale Hydrogel Shells 24

Photodynamic Therapy and Gold 25

Dendrimer Conjugates 26

Ligand-targeted Emulsion Technologies 26

Linear Cyclodextrin-containing Polymers 27

Smart Lipid-based Nanocarriers 27

Thermotherapy Using Magnetic Nanoparticles 28

Targeted Cell Destruction 28

Nanoshells 29

DRUG DELIVERY 29

Acusphere 29

AlphaRx 30

Aphios 30

Biodelivery Sciences 30

Bioral 31

Capsulution NanoScience 31

HealthPlus International 32

IGI 32

Labopharm 32

MagnaMedics 33

Nanocopoeia 33

Nanocrystal 33

NanoMed 34

Nanopharm 34

Nanocyte 35

Nanotherapeutics 35

Nanotrope 36

pSivida 36

SoluBest 37

Spherics 37

Telemolecular 37

INFECTION CONTROL 38

Silver Nanoparticles Against Infection 38

Detecting Nanobacteria 39

Killing Viruses 40

DIAGNOSTIC TOOLS 40

BioCrystal/InVitrogen 40

BioForce 41

Biophage 41

CombiMatrix 41

Farfield Sensors 42

GE Healthcare BioSciences 42

Immunicon 43

MagnaMedics 43

Nanogen 44

NanoSphere 44

Qiagen 45

Sphere 45

TransGenex 46

Veredus 46

VARIOUS THERAPEUTIC TARGETS AND TECHNOLOGIES 47

Anthrax 47

Cholesterol 47

Artificial Retina 47

Nerve Regeneration 48

Crossing the Blood-Brain Barrier 48

Protecting Against Radiation Damage 49

Antibody Therapeutics 50

Hemostasis 50

Bone Fracture Repair 51

Dental Implant and Tissue Regeneration 51

Vaccine Adjuvant 51

Treatment of Thrombosis 52

Coatings for Stents and Other Devices 53

FUTURE TRENDS AND RESEARCH POSSIBILITIES 53

Noninvasive Nanodevices 54

Extracellular Devices 55

Intracellular Devices 55

Nanomachines to Control Tissue Healing 56

Eliminating Viruses 57

Correcting Chemistry 58

New Organs and Limbs 58

FUNDAMENTAL NANOTECHNOLOGY RESEARCH 58

U.S. 59

University at Albany-SUNY 59

Cornell University 59

University of Michigan 60

Rice University 60

University of Pennsylvania 61

University of Virginia 62

University of North Carolina 62

Ohio State University 63

Northwestern University 63

University of Pittsburgh 63

Case Western Reserve University 64

University of California at Berkeley 64

Europe 64

TABLE 7 EUROPEAN NANOCENTERS 65

Japan 65

Development of Active Targeting DDS 66

Development of Novel Tissue Engineering 66

Development of New Biomaterials 66

THE RISK FACTOR 67

MARKETS FOR NANOMEDICINE 68

TABLE 8 MARKETED NANOPHARMACEUTICALS 69

TABLE 9 MARKETED NANO-IMAGING, DIAGNOSTICS, BIOMATERIALS 70

MARKET DRIVERS 70

MARKET ESTIMATES AND FORECASTS 71

TABLE 10 NANOTECHNOLOGY REVENUES BY INDUSTRY SECTOR, 2010 (%) 71

Global Nanomedicine Market 72

TABLE 11 GLOBAL NANOMEDICINE MARKET, THROUGH 2014 ($ BILLIONS) 72

Main Product Categories 72

Drug Delivery 72

Molecular Diagnostics 73

Market Analysis by Clinical Application 74

Cancer 74

TABLE 12 MAJOR MARKETED ANTICANCER NANOPHARMACEUTICALS, 2008 ($ BILLIONS) 74

TABLE 13 MARKET FORECAST FOR CANCER NANOTHERAPEUTICS AND ANODIAGNOSTICS, THROUGH
2014 ($ BILLIONS) 75

CNS Disorders 75

TABLE 14 MAJOR MARKETED CNS NANOPHARMACEUTICALS, 2008 ($ MILLIONS) 75

TABLE 15 MARKET FORECAST FOR CNS NANOMEDICINES, THROUGH 2014 ($ BILLIONS) 76

Infection 76

TABLE 16 MAJOR MARKETED ANTI-INFECTIVE NANOPHARMACEUTICALS, 2008 ($ BILLIONS) 76

TABLE 17 MARKET FORECAST FOR ANTI-INFECTION NANOTHERAPEUTICS AND
NANODIAGNOSTICS, THROUGH 2014 ($ BILLIONS) 77

Cardiovascular and Autoimmune Disorders 77

TABLE 18 MAJOR MARKETED NANOMEDICINES FOR CARDIOVASCULAR AND INFLAMMATORY
DISEASES, 2008 ($ MILLIONS) 77

TABLE 19 MARKETS FOR CARDIOVASCULAR AND ANTI-INFLAMMATORY PRODUCTS, THROUGH 2014
($ BILLIONS) 78

Regional and National Market Analysis 78

FIGURE 1 NATIONAL SHARES OF THE GLOBAL NANOMEDICINE MARKETPLACE, 2009 (%) 78

FIGURE 1 (CONTINUED) 79

U.S. 79

TABLE 20 U.S. NANOMEDICINE MARKET: HISTORIC AND FORECAST DATA, THROUGH 2014 ($
BILLIONS/%) 79

Japan 80

TABLE 21 NANOMEDICINE MARKET IN JAPAN: HISTORIC AND FORECAST DATA, THROUGH 2014
($ BILLIONS/%) 80

Europe 81

TABLE 22 NANOMEDICINE MARKET IN GERMANY: HISTORIC AND FORECAST DATA, THROUGH
2014 ($ BILLIONS/%) 81

TABLE 23 NANOMEDICINE MARKET IN FRANCE: HISTORIC AND FORECAST DATA, THROUGH 2014
($ BILLIONS/%) 81

TABLE 24 NANOMEDICINE MARKET IN UNITED KINGDOM: HISTORIC AND FORECAST DATA,
THROUGH 2014 ($ BILLIONS/%) 82

TABLE 25 NANOMEDICINE MARKET IN ITALY: HISTORIC AND FORECAST DATA, THROUGH 2014
($ BILLIONS/%) 82

TABLE 26 NANOMEDICINE MARKET IN SPAIN: HISTORIC AND FORECAST DATA, THROUGH 2014
($ BILLION/%) 82

Europe (Continued) 83

Chapter-5: COMPANY PROFILES

ABLYNX NV 84

ABRAXIS BIOSCIENCE 85

ABRAXIS BIOSCIENCE (CONTINUED) 86

ACRYMED INC. 87

ACUSPHERE INC. 88

ACUSPHERE INC. (CONTINUED) 89

ADVANCED MAGNETICS 90

ALLTRACEL 90

ALPHARX INC. 91

ALPHARX INC. (CONTINUED) 92

ANSON NANO-BIOTECHNOLOGY 93

APHIOS CORP. 93

PROTEIN NANOPARTICLES 94

POLYMER NANOSPHERES 94

PHOSPHOLIPID NANOSOMES 94

BIOCRYSTAL LTD 95

BIOFORCE NANOSCIENCES INC. 96

THE VIRICHIP VIRUS DETECTION PLATFORM 96

BIO-GATE AG 97

MEDICAL APPLICATIONS 98

BIOPHAGE PHARMA INC. 99

PRODUCTS 99

DEVELOPMENT THROUGH COLLABORATIONS: 99

PHAGES 100

BIOPHAN TECHNOLOGIES 101

BIOSANTE PHARMACEUTICALS INC. 102

NOVEL VACCINE ADJUVANT-BIOVANT 102

THERAPEUTIC DRUG DELIVERY PLATFORM--BIOAIR /BIOORAL 103

CALANDO PHARMACEUTICALS 104

C SIXTY 105

C SIXTY (CONTINUED) 106

CAPSULUTION PHARMA AG 107

DRUG DELIVERY SYSTEMS 107

COMBIMATRIX 108

DRUG DEVELOPMENT 108

Drug Development (Continued) 109

DAMAGE PREVENTION CONCEPT 110

ELAN DRUG TECHNOLOGIES 110

ELAN DRUG TECHNOLOGIES (CONTINUED) 111

FARFIELD SCIENTIFIC 112

FARFIELD SCIENTIFIC (CONTINUED) 113

GE HEALTHCARE LIFE SCIENCES 114

HEALTHPLUS INTERNATIONAL INC. 115

IGI INC. 116

IMARX THERAPEUTICS INC. 117

SONOLYSIS 118

JR NANOTECH PLC 119

KEREOS, INC. 119

MRI AGENT FOR TUMOR DETECTION 120

TARGETED CHEMOTHERAPEUTICS FOR SOLID TUMORS 120

KI-0002 MRI AGENT FOR CARDIOVASCULAR DISEASE DETECTION 120

ANTI-RESTENOTIC 120

KEYSTONE NANO, INC. 121

NANOJACKETS 121

KLEINDIECK NANOTECHNIK 122

NANOWORKSTATION 122

LABOPHARM INC. 123

LABOPHARM INC. (CONTINUED) 124

LIPLASOME PHARMA 125

LIPLASOME PHARMA (CONTINUED) 126

LUMERA CORPORATION 127

NANOCAPTURE MICROARRAYS 128

MAGFORCE NANOTECHNOLOGIES AG 128

MAGFORCE NANOTECHNOLOGIES AG (CONTINUED) 129

MAGNAMEDICS GMBH 130

MAGCUSTOM 130

Customized Nano- and Micro-Particles 130

EFFICIENT AND LOW-COST DIAGNOSTICS 131

MULTIFUNCTIONAL DRUG CARRIER 131

MICROFLUIDICS INTERNATIONAL CORPORATION 132

MIV THERAPEUTICS INC. 133

CARDIOVASCULAR HEART STENTS 134

MOLECULAR PROFILES 135

NANOBAC PHARMACEUTICALS INC 136

NANOBIO CORPORATION 137

NANOBIO CORPORATION (CONTINUED) 138

NANOBIO CORPORATION (CONTINUED) 139

NANOBIOTIX 140

NANOBIOTIX (CONTINUED) 141

NANOCARRIER CO. LTD. 142

NANOCARRIER CO. LTD. (CONTINUED) 143

NANOCOPOEIA 144

NANOCYTE INC 145

NANOGEN INC. 146

ELECTRONIC MICROARRAY 147

INSTRUMENTATION 147

Molecular Biology Workstation 147

Molecular Biology Workstation Cartridge 148

NanoChip 400 System 148

NANOINK INC. 149

NANOLOGIX INC. 150

NANOMED PHARMACEUTICALS, INC. 151

NANOMIX INC. 152

NANOPHARM AG 153

NANOSPECTRA BIOSCIENCES, INC. 154

NANOSPHERE INC. 155

NANOSPHERE INC. (CONTINUED) 156

NANOSTRUCTURES INC. 157

NANOSYN INC 158

NANOTHERAPEUTICS INC. 159

NANOTHERAPEUTICS INC. (CONTINUED) 160

NANOTROPE INC. 161

NANOVIRICIDES INC. 162

FLUCIDE-I 162

NUCRYST PHARMACEUTICALS 163

WEBSITE: WWW.NUCRYST.COM 163

NUCRYST PHARMACEUTICALS (CONTINUED) 164

NUTRALEASE 165

ORION INTEGRATED BIOSCIENCES INC. 166

GENOMIC SIGNATURES 166

RATIONAL ANTIVIRAL DEVELOPMENT 167

DISCOVERY OF MALARIA INVASION PATHWAYS 167

ORTHOVITA INC 168

PIONEER SURGICAL TECHNOLOGY 169

PSIVIDA LTD 169

PSIVIDA LTD (CONTINUED) 170

QIAGEN N.V. 171

SOLUBEST LTD. 172

SOLUBEST LTD. (CONTINUED) 173

SPHERICS INC. 174

STARPHARMA HOLDINGS LTD 175

DENDRIMER NANOTECHNOLOGY 175

TECAN GROUP LTD. 176

TEMOLECULAR CORPORATION 177

TEMOLECULAR CORPORATION (CONTINUED) 178

TEMOLECULAR CORPORATION (CONTINUED) 179

TRANSGENEX NANOBIOTECH INC. 180

THERAPY 181

APPENDIX: GLOSSARY OF TERMS 182

TABLE 27 GLOSSARY OF TERMS 182

TABLE 27 (CONTINUED) 183

TABLE 27 (CONTINUED) 184

To order this report:

Nanotechnology Industry: Nanotechnology in Medical Applications: The Global Market

www.reportlinker.com/p0170502/Nanotechnology-in-Medical-Applications-The-Global-Market.html